Adams GC, Devlin JE, Klontz E, Laing RA, Branda JA. Development of a Combined Clinical and Research-Developed Testing Strategy for Highly Pathogenic Avian Influenza A Virus H5. Open Forum Infect Dis. 2025 Dec 10;13(1):ofaf744
Highly pathogenic avian influenza A (H5) virus continues to spread in animals with ongoing concern for potential human transmission. We describe an adaptable H5 screening approach that integrates clinical laboratory workflows with research-developed assays. This strategy efficiently screened thousands of samples, providing a practical and scalable model for H5 surveillance.
See Also:
Latest articles in those days:
- A single mutation in nonstructural protein 1 is critical for the adaptive evolution of influenza B virus 7 hours ago
- Fatal human H3N8 influenza virus has a moderate pandemic risk 7 hours ago
- No evidence of influenza A virus infection in marine mammals stranded in Basque Country coast (Northern Spain) in the context of H5N1 clade 2.3.4.4b expansion 7 hours ago
- Antibodies Elicited by the 2025-2026 Influenza Vaccine 7 hours ago
- Global evolutionary landscape of H11 avian influenza and initial isolates identified in Xinjiang, China 1 days ago
[Go Top] [Close Window]
